<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38099612</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">0972-2823</ISSN><JournalIssue CitedMedium="Internet"><Volume>70</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of postgraduate medicine</Title><ISOAbbreviation>J Postgrad Med</ISOAbbreviation></Journal><ArticleTitle>Creatine supplementation combined with breathing exercises reduces respiratory discomfort and improves creatine status in patients with long-COVID.</ArticleTitle><Pagination><StartPage>101</StartPage><EndPage>104</EndPage><MedlinePgn>101-104</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/jpgm.jpgm_650_23</ELocationID><Abstract><AbstractText>Eight long-COVID patients with moderate fatigue that had lasted for &#x2265;3 months were recruited. All patients were allocated in a double-blind parallel-group design to receive either 4 g of creatine per day plus breathing exercises (study group) or breathing exercises only (control group) for 3 months. Creatine induced a significant increase in tissue total creatine levels for all 14 locations evaluated in the present study ( P &lt; 0.05), while its levels significantly dropped in the right frontal gray matter and left parietal mesial gray matter at follow-up in the control group ( P &lt; 0.05). No change in time to exhaustion was demonstrated in the control group (P &gt; 0.05), while the mean time to exhaustion was significantly improved for 54 s in the study group post-administration (P = 0.05). These preliminary findings suggest that creatine is as an effective adjuvant therapeutic to breathing exercises for tackling the clinical features in long-COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Copyright: &#xa9; 2023 Journal of Postgraduate Medicine.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Slankamenac</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Applied Bioenergetics Lab, Faculty of Sport and PE, University of Novi Sad, Novi Sad, Serbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranisavljev</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Todorovic</LastName><ForeName>N</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Ostojic</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Stajer</LastName><ForeName>V</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Ostojic</LastName><ForeName>S M</ForeName><Initials>SM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>India</Country><MedlineTA>J Postgrad Med</MedlineTA><NlmUniqueID>2985196R</NlmUniqueID><ISSNLinking>0022-3859</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003401" MajorTopicYN="Y">Creatine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001945" MajorTopicYN="Y">Breathing Exercises</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="Y">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>SMO serves as a member of the Scientific Advisory Board on creatine in health and medicine (AlzChem LLC). SMO co-owns the patent &#x201c;Supplements Based on Liquid Creatine&#x201d; at the European Patent Office (WO2019150323 A1). SMO has received research support related to creatine during the past 36 months from the Serbian Ministry of Education, Science, and Technological Development; Provincial Secretariat for Higher Education and Scientific Research; AlzChem Group AG; ThermoLife International; and Hueston Hennigan LLP. SMO does not own stocks and shares in any organization. JS, MR, NT, JO, and VS declare no known competing financial interests or personal relationships that could have appeared to influence the authorship of this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>21</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>15</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>15</Day><Hour>8</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38099612</ArticleId><ArticleId IdType="pmc">PMC11160995</ArticleId><ArticleId IdType="doi">10.4103/jpgm.jpgm_650_23</ArticleId><ArticleId IdType="pii">00005257-202470020-00010</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention. Long COVID or Post-COVID Conditions.  [[Last assessed on 2023 Jun 22]].  Available from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html .</Citation></Reference><Reference><Citation>American Thoracic Society. Report of an ad-hoc International Task Force on early and short-term rehabilitative interventions in COVID-19 survivors. 2020.  [[Last assessed on 2023 Jun 22]].  Available from: https://www.thoracic.org/members/assemblies/assemblies/pr/journal-club/report-of-anad-hoc-international-task-force-to-develop-an-expert-based-opinion.php .</Citation></Reference><Reference><Citation>Kessler A, Heightman M, Brennan E. Post-COVID-19 respiratory problems: Burden and management. Curr Opin Support Palliat Care. 2022;16:203&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">36326730</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha S, Sharma K. Modification of lifestyle to recover from post-covid symptoms: A short review. J Lifestyle Med. 2022;12:113&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9798880</ArticleId><ArticleId IdType="pubmed">36628181</ArticleId></ArticleIdList></Reference><Reference><Citation>Slankamenac J, Ranisavljev M, Todorovic N, Ostojic J, Stajer V, Ostojic SM. Effects of six-month creatine supplementation on patient- and clinician-reported outcomes, and tissue creatine levels in patients with post-COVID-19 fatigue syndrome. Food Sci Nutr. 2023;11:6899&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10630839</ArticleId><ArticleId IdType="pubmed">37970399</ArticleId></ArticleIdList></Reference><Reference><Citation>Dos Santos EEP, de Ara&#xfa;jo RC, Candow DG, Forbes SC, Guijo JA, de Almeida Santana CC, et al. Efficacy of creatine supplementation combined with resistance training on muscle strength and muscle mass in older females: A systematic review and meta-analysis. Nutrients. 2021;13:3757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8619193</ArticleId><ArticleId IdType="pubmed">34836013</ArticleId></ArticleIdList></Reference><Reference><Citation>Solis MY, Artioli GG, Gualano B. Potential of creatine in glucose management and diabetes. Nutrients. 2021;13:570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7915263</ArticleId><ArticleId IdType="pubmed">33572228</ArticleId></ArticleIdList></Reference><Reference><Citation>Derosa G, Pasqualotto S, Catena G, D'Angelo A, Maggi A, Maffioli P. A randomized, double-blind, placebo-controlled study to evaluate the effectiveness of a food supplement containing creatine and d-ribose combined with a physical exercise program in increasing stress tolerance in patients with ischemic heart disease. Nutrients. 2019;11:3075.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6950237</ArticleId><ArticleId IdType="pubmed">31861049</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairman CM, Kendall KL, Newton RU, Hart NH, Taaffe DR, Chee R, et al. Examining the effects of creatine supplementation in augmenting adaptations to resistance training in patients with prostate cancer undergoing androgen deprivation therapy: A randomised, double-blind, placebo-controlled trial. BMJ Open. 2019;9:e030080.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6756416</ArticleId><ArticleId IdType="pubmed">31542747</ArticleId></ArticleIdList></Reference><Reference><Citation>Stout JR, Eckerson JM, May E, Coulter C, Bradley-Popovich GE. Effects of resistance exercise and creatine supplementation on myasthenia gravis: A case study. Med Sci Sports Exerc. 2001;33:869&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">11404649</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreider RB, Stout JR. Creatine in health and disease. Nutrients. 2021;13:447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7910963</ArticleId><ArticleId IdType="pubmed">33572884</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranisavljev M, Todorovic N, Ostojic J, Ostojic SM. Reduced tissue creatine levels in patients with long COVID-19: A cross-sectional study. J Postgrad Med. 2023;69:162&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10394531</ArticleId><ArticleId IdType="pubmed">37171415</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>